CFMS Stock - Conformis, Inc.
Unlock GoAI Insights for CFMS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $62.05M | $99.86M | $68.76M | $77.43M | $89.79M |
| Gross Profit | $23.21M | $65.68M | $33.72M | $36.74M | $48.48M |
| Gross Margin | 37.4% | 65.8% | 49.0% | 47.4% | 54.0% |
| Operating Income | $-46,278,000 | $68,000 | $-25,114,000 | $-25,129,000 | $-38,692,000 |
| Net Income | $-50,473,000 | $-2,413,000 | $-24,293,000 | $-28,478,000 | $-43,365,000 |
| Net Margin | -81.3% | -2.4% | -35.3% | -36.8% | -48.3% |
| EPS | $-6.99 | $-0.36 | $-8.47 | $-11.10 | $-18.41 |
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Visit WebsiteEarnings History & Surprises
CFMSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Jul 31, 2024 | — | — | — | — |
Q2 2024 | May 6, 2024 | — | — | — | — |
Q1 2024 | Feb 28, 2024 | — | — | — | — |
Q4 2023 | Nov 1, 2023 | $-1.40 | — | — | — |
Q3 2023 | Aug 2, 2023 | $1.32 | $1.78 | +34.8% | ✓ BEAT |
Q2 2023 | May 8, 2023 | $1.56 | $1.32 | -15.4% | ✗ MISS |
Q1 2023 | Mar 1, 2023 | $1.84 | $0.51 | -72.3% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $1.75 | $2.00 | +14.3% | ✓ BEAT |
Q3 2022 | Aug 8, 2022 | $2.00 | $2.25 | +12.5% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $1.75 | $2.25 | +28.6% | ✓ BEAT |
Q1 2022 | Mar 2, 2022 | $2.00 | $2.25 | +12.5% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | $1.75 | $1.75 | 0.0% | = MET |
Q3 2021 | Aug 4, 2021 | $1.06 | $5.25 | +395.3% | ✓ BEAT |
Q2 2021 | May 5, 2021 | $2.00 | $2.25 | +12.5% | ✓ BEAT |
Q1 2021 | Mar 3, 2021 | $2.75 | $2.00 | -27.3% | ✗ MISS |
Q4 2020 | Nov 4, 2020 | $3.00 | $2.25 | -25.0% | ✗ MISS |
Q3 2020 | Aug 5, 2020 | $3.25 | $0.75 | -76.9% | ✗ MISS |
Q2 2020 | May 11, 2020 | $2.25 | $3.50 | +55.6% | ✓ BEAT |
Q1 2020 | Mar 2, 2020 | $2.50 | $2.00 | -20.0% | ✗ MISS |
Q4 2019 | Oct 30, 2019 | $2.75 | $3.25 | +18.2% | ✓ BEAT |
Latest News
Frequently Asked Questions about CFMS
What is CFMS's current stock price?
What is the analyst price target for CFMS?
What sector is Conformis, Inc. in?
What is CFMS's market cap?
Does CFMS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CFMS for comparison